Each CD includes the full-color, searchable, PDF files of articles and formulations from the Journal.

CD Prices
1 = $95
2 to 5 = $85 each
6 to 9 = $75 each
10 + = $65 each

Library CD
Volume 4, 2000 CD
Six back issues from 2000 on one convenient CD.
Permanent storage and easy retrieval of IJPC articles and formulations.
Only $95 per CD
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

This CD contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 4 No. 1 January/February 2000 Compounding for Pain Management
Vol. 4 No. 2 March/April 2000 Compounding for Diabetes Patients
Vol. 4 No. 3 May/June 2000 Compounding for the Ear, Nose and Throat
Vol. 4 No. 4 July/August 2000 Compounding for Hospice and Cancer Patients
Vol. 4 No. 5 September/October 2000 Compounding for Immune System Disorders
Vol. 4 No .6 November/December 2000 Compounding for Hormone Replacement Therapy

Volume 4, 2000 CD ARTICLES

Volume4, 2000 CD ARTICLES
Title (Click for Details) Vol/Issue Page
Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium Vol. 4 No. 1 6
The Psychology of Pain Vol. 4 No. 1 12
Opioids: A Review of the Pharmacology Vol. 4 No. 1 17
Fibromyalgia Vol. 4 No. 1 21
Compounding Intrathecal Medications Vol. 4 No. 1 24
Book Review: The NMDA Receptor Vol. 4 No. 1 26
Postherpetic Neuralgia Vol. 4 No. 1 27
Compounding Software: An Evaluation Vol. 4 No. 1 32
Marketing Your Prescription Compounding Practice: Part One Vol. 4 No. 1 36
Marketing Tip: Marketing Reps Can Help Vol. 4 No. 1 39
Profile of a Practice Vol. 4 No. 1 40
Particulates in Parenterals Vol. 4 No. 1 43
The Basics of Compounding: Compounding Medication Sticks Vol. 4 No. 1 44
Clear-Stick Base Vol. 4 No. 1 45
Styptic Pencil Vol. 4 No. 1 45
Styptic Pencil (Crayon Type) Vol. 4 No. 1 45
Analgesic Medication Stick Vol. 4 No. 1 45
Amitriptyline HCl 2% and Baclofen 2% in PLO Vol. 4 No. 1 50
Capsaicin 0.075%, Ketamine HCl 2% and Ketoprofen 10% in PLO Vol. 4 No. 1 51
Capsicum 0.32%, Methyl Salicylate 25% and Menthol 10% Analgesic Cream Vol. 4 No. 1 52
Clonidine HCl 1-mg/g in VanPen Cream Vol. 4 No. 1 53
Cyclobenzaprine 1% and Guaifenesin 10% in Speed Gel Vol. 4 No. 1 54
Dyclonine HCl 1-mg and Diphenhydramine HCl 10-mg Anesthetic Troches Vol. 4 No. 1 55
Fentanyl 50-mcg Chewable Gummy Gels Vol. 4 No. 1 56
Fentanyl 25-mcg/0.1-mL Nasal Spray Vol. 4 No. 1 57
Morphine Sulfate 2.5-mg/mL Inhalation Solution Vol. 4 No. 1 58
Shingles Ointment/Cream Vol. 4 No. 1 59
Stiffening Agents, Featured Excipient: Vol. 4 No. 1 60
Calculations Vol. 4 No. 1 63
Calibration of Hot Plates Vol. 4 No. 1 65
Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection Vol. 4 No. 1 66
Naratriptan HCl in Extemporaneously Compounded Oral Suspensions Vol. 4 No. 1 69
Physicochemical Stability of Compounded Creams Containing alpha-Hydroxy Acids Vol. 4 No. 1 72
The Clinical Pharmacist's Role in Compounding for the Diabetic Patient Vol. 4 No. 2 84
Sugar Substitutes Vol. 4 No. 2 86
Complications of Diabetes Vol. 4 No. 2 88
Transdermal Gels in the Treatment of Diabetic Neuropathy Vol. 4 No. 2 91
L-Arginine and Ascorbic Acid for Diabetic Foot Ulcers Vol. 4 No. 2 94
Natural-Product Therapies for Treating Diabetic Neuropathy Vol. 4 No. 2 98
Patient Handout: Diabetes Management Guidelines Vol. 4 No. 2 100
Complementary Medicine - A Wellness Plan for People with Diabetes Vol. 4 No. 2 101
Diabetes Book Reviews Vol. 4 No. 2 103
Analytical Testing of Extemporaneously Compounded Preparations Vol. 4 No. 2 105
Natural Estrogens: A Review of the Primary Literature Vol. 4 No. 2 110
Marketing Your Prescription Compounding Practice: Part Two Vol. 4 No. 2 115
Profile of a Practice Vol. 4 No. 2 120
Basics of Compounding: Compounding Solutions Vol. 4 No. 2 122
Chlorhexidine 0.2% Oral Rinse Vol. 4 No. 2 128
Coenzyme Q10 200-mg Chewable Troches Vol. 4 No. 2 129
Diabetic Foot-Care Ointments Vol. 4 No. 2 130
Diabetic Skin-Ulcer Cream Vol. 4 No. 2 131
Ketamine HCl 5% and Amitriptyline HCl 2% in PLO Vol. 4 No. 2 132
Ketamine HCl 10%, Gabapentin 6%, Baclofen 2%, Amitriptyline HCl 2% and Clonidine HCl 0.1% in PLO Vol. 4 No. 2 133
Lipoic Acid 200-mg Chewable Troches Vol. 4 No. 2 134
Nifedipine 160-mg/mL in PLO Vol. 4 No. 2 135
Sugar-Free Suspension Structured Vehicle, USP Vol. 4 No. 2 136
Vanadyl Sulfate 10-mg Capsules Vol. 4 No. 2 137
Official Solvents, Featured Excipient: Vol. 4 No. 2 139
Standard Operating Procedure for Cleaning Glassware Vol. 4 No. 2 144
Calculations Vol. 4 No. 2 145
Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution Vol. 4 No. 2 146
Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration Vol. 4 No. 2 150
Effect of Some Antioxidants on the Color Change of White Lotion Vol. 4 No. 2 154
Compounding Ear, Nose and Throat Preparations Vol. 4 No. 3 164
Benzocaine Otic Solution Vol. 4 No. 3 165
General Nasal Solution Vehicle Vol. 4 No. 3 166
Desmopressin Acetate Nasal Solution 0.033 mg/mL Vol. 4 No. 3 167
Saline Nasal Mist Vol. 4 No. 3 167
Atropine Sulfate 0.5% Nasal Solution Vol. 4 No. 3 167
Xylometazoline 1-mg/mL HCl Nasal Drops Vol. 4 No. 3 169
Progesterone 20-mg/mL Nasal Solution Vol. 4 No. 3 169
Scopolamine Hydrobromide 0.4-mg per 0.1-mL Nasal Solution Vol. 4 No. 3 169
Xylitol in the Prevention of Otitis Media Vol. 4 No. 3 171
Xylitol 40% Syrup Vol. 4 No. 3 174
Xylitol Troches Vol. 4 No. 3 174
Sildenafil 0.2% Otic Drops Vol. 4 No. 3 175
Xerostomia Vol. 4 No. 3 176
Pilocarpine Oral Solution Vol. 4 No. 3 177
Pharmacological Treatment Options for Snoring Vol. 4 No. 3 179
Compounding OTC Drugs: A Legal Perspective Vol. 4 No. 3 180
Needleless Infusion Systems Vol. 4 No. 3 183
Pharmacy Licensure Requirements Vol. 4 No. 3 184
Wish You Were Here: Oklahoma Frontier Drug Store Museum Vol. 4 No. 3 188
Three Drug Stability Lives Vol. 4 No. 3 190
Cellulose Applications for the Pharmaceutical Industry Vol. 4 No. 3 196
Marketing Your Prescription Compounding Practice: Part Three Vol. 4 No. 3 199
Profile of a Practice: Surviving the Competition Vol. 4 No. 3 203
The Future of Compounding: An Industry Perspective Vol. 4 No. 3 204
Amphotericin B 100-mg Troches Vol. 4 No. 3 208
Dimethyl Sulfone 16% Nasal Solution Vol. 4 No. 3 209
Miconazole 2% Otic Powder Vol. 4 No. 3 210
Misoprostol 0.001% and Lidocaine 0.5% Oral Rinse Vol. 4 No. 3 211
Misoprostol 0.0027% Mucoadhesive Powder Vol. 4 No. 3 212
Mupirocin 1% Nasal Drops Vol. 4 No. 3 213
Nystatin 250,000-Unit and/or Tetracaine HCl 0.025% Popsicles Vol. 4 No. 3 214
Saliva Substitute for Dry Mouth/Throat Vol. 4 No. 3 215
Stomatitis Preparations Vol. 4 No. 3 216
Tonicity-Adjusting Agents, Featured Excipient: Vol. 4 No. 3 218
Calculations Vol. 4 No. 3 221
Assignment of Beyond-Use Dates Vol. 4 No. 3 222
Dry Heat Sterilization of Parenteral Oil Vehicles Vol. 4 No. 3 223
Stability of Morphine-Ketamine Mixtures in 0.9% Sodium Chloride Injection Packaged in Syringes, Plastic Bags and MEDICATION CASSETTEª Reservoirs Vol. 4 No. 3 225
Simple High-Performance Liquid Chromatographic Method for Simultaneous Determination of Fusidic Acid and Betamethasone Dipropionate in a Cream Formulation Vol. 4 No. 3 229
Stability of an Oral Liquid Dosage Form of Trovafloxacin Mesylate and Its Quantitation in Tablets Using High-Performance Liquid Chromatography Vol. 4 No. 3 233
Hospice and the Role of the Compounding Pharmacist Vol. 4 No. 4 246
Nausea and Vomiting in Hospice Patients Vol. 4 No. 4 250
Ketamine for Pain in Hospice Patients Vol. 4 No. 4 253
Custom-Making Medications for the Hospice Patient Vol. 4 No. 4 255
Body-Wash Formula Vol. 4 No. 4 255
Rinseless Shampoo Vol. 4 No. 4 255
Dry Mouth Spray Vol. 4 No. 4 255
Surviving Cancer - How the Compounding Pharmacist Can Help Vol. 4 No. 4 257
Compounding Using Hazardous Drugs Vol. 4 No. 4 261
Providing Positive Outcomes through Compounding for Animal Cancer Patients Vol. 4 No. 4 264
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease Vol. 4 No. 4 276
NADH Capsules Vol. 4 No. 4 278
Short Communication: Compounding for Implantable Pumps Vol. 4 No. 4 280
Ambulatory Pumps: Part I of a Three-Part Series - Peristaltic Infusion Devices Review Vol. 4 No. 4 281
Profile of a Practice Vol. 4 No. 4 287
Book Reviews Vol. 4 No. 4 288
Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations Vol. 4 No. 4 289
Dacarbazine 8-mg/mL, Doxorubicin HCl 0.8-mg/mL and Ondansetron 0.64-mg/mL injection Vol. 4 No. 4 296
Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metoclopramide HCl 2.4% in PLO Vol. 4 No. 4 297
Doxorubicin HCl 0.4-mg/mL, Ondansetron HCl 0.48-mg/mL and Vincristine Sulfate 14-mcg/mL Injection Vol. 4 No. 4 298
Fentanyl 100-mcg/0.1-mL and Promethazine HCl 12.5-mg/0.1-mL in PLO Vol. 4 No. 4 299
Fentanyl 35-mcg/mL, Bupivacaine HCl 1-mg/mL and Clonidine HCl 9-mcg/mL Intrathecal Solution Vol. 4 No. 4 300
Lidocaine HCl 2%, Misoprostol 0.003% and Phenytoin 2.5% Topical Gel for Decubitus Ulcers Vol. 4 No. 4 301
Misoprostol 0.0024% Mouth Rinse for Oral Ulcerations Vol. 4 No. 4 302
Morphine Sulfate 20-mg/mL and Clonidine HCl 10-mcg/mL Epidural Injection Vol. 4 No. 4 303
Nasogastric Tube/Percutaneous Endoscopic Gastrostomy Tube Suspension Formula Vol. 4 No. 4 304
Ondansetron HCl 8-mg/mL in PLO Vol. 4 No. 4 305
Capsule and Tablet Diluents, Featured Excipient: Vol. 4 No. 4 306
Basic Compounding Documentation: The Master Formula Form Vol. 4 No. 4 313
Calculations Vol. 4 No. 4 314
Experimenting with a New Emulsifying Agent (Tahini) in Mineral Oil Emulsion Vol. 4 No. 4 315
Microbiological Stability of a Fentanyl, Bupivacaine and Clonidine Mixture in a 0.9% Sodium Chloride Infusion Stored in Syringes and Reservoirs Vol. 4 No. 4 318
Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution Vol. 4 No. 4 320
Human Immunodeficiency Virus and the Acquired Immune Deficiency Syndrome Vol. 4 No. 5 334
Clinical Management and Review of Sjogren's Syndrome Vol. 4 No. 5 338
Sodium Fluoride Gel (0.5% Fluoride) Vol. 4 No. 5 339
Clotrimazole 10 mg Base A Troche Vol. 4 No. 5 339
Saliva Substitute Vol. 4 No. 5 340
Compounding with Beta-1, 3-D-Glucan Vol. 4 No. 5 342
Psoriasis Vol. 4 No. 5 346
Probiotics and Their Effect on Leaky Gut Syndrome and Associated Diseases Vol. 4 No. 5 349
Immune System Disorders: What's new and Interesting in Print and On-Line Vol. 4 No. 5 351
Transdermal Nifedipine for Wound Healing: Case Reports Vol. 4 No. 5 356
Wish You Were Here: Marvin Samson Center for the History of Pharmacy, University of the Sciences in Philadelphia Vol. 4 No. 5 359
Profile of A Practice: Hormone Replacement Therapy in the Heartland Vol. 4 No. 5 362
Ambulatory Syringe Infusion Devices: A Review - Part 2 Vol. 4 No. 5 364
Basics of Compounding: Compounding Suppositories Part 2 Vol. 4 No. 5 371
Artificial Tears for Dry Eyes Vol. 4 No. 5 376
Capsicum Oleoresin 0.3% and Ketoprofen 10% in PLO Gel Vol. 4 No. 5 377
Coal Tar Medication Stick Vol. 4 No. 5 378
Interferon with 0.1% Nonoxynol-9 Gel Vol. 4 No. 5 379
Interferon Ophthalmic Solution Vol. 4 No. 5 380
Pilocarpine HCl 2-mg Troches Vol. 4 No. 5 381
Psoriasis Nail Treatment Vol. 4 No. 5 382
Psoriasis Ointment, Heavy Moisturizing Vol. 4 No. 5 383
Sunscreen Gel-Alcoholic, SPF-15 Vol. 4 No. 5 384
Sunscreen Lotion, SPF-40 Vol. 4 No. 5 385
Providing Care for Diabetic Veterinary Patients Vol. 4 No. 5 386
Capsule and Tablet Lubricants, Featured Excipient: Vol. 4 No. 5 390
Calculations Vol. 4 No. 5 393
Basic Compounding Documentation: The Batch Control Sheet Vol. 4 No. 5 395
Stability of Hydrocortisone Sodium Succinate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 4 No. 5 396
Stability of Lisinopril Syrup (2 mg/mL) Extemporaneously Compounded from Tablets Vol. 4 No. 5 398
Pharmaceutical Profile of Vitamin C Tablets and Capsules Vol. 4 No. 5 400
"Natural" Isomolecular Hormone Replacement: An Evidence-Based Medicine Approach Vol. 4 No .6 414
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens-Part 1 Vol. 4 No .6 421
Book Reviews: Women's Health Vol. 4 No .6 424
Hormone Replacement Therapy: Selected Recent References Vol. 4 No .6 426
Testosterone Deficiency in Men: New Treatments for Andropause Vol. 4 No .6 429
Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists Vol. 4 No .6 432
Zinc Sulfate Heptahydrate 0.1% Solution Vol. 4 No .6 440
Managing Zinc Deficiency in an Office Setting Vol. 4 No .6 440
Disposable Ambulatory Infusion Devices: A Review - Part 3 Vol. 4 No .6 442
On-Line Billing for Custom Compounds: The Third-Party Payor Vol. 4 No .6 445
Fentanyl Troche Protocol Vol. 4 No .6 447
Profile of a Practice: Med Specialties Pharmacy Vol. 4 No .6 448
Wish You Were Here: Donald F. Salvatori California Pharmacy Museum Vol. 4 No .6 450
Basics of Compounding - Inhalation Preparations Vol. 4 No .6 452
Albuterol Sulfate 0.5% Inhalant Solution (Preservative Free) Vol. 4 No .6 455
Flunisolide 0.025% Inhalation Solution (Preservative Free) Vol. 4 No .6 455
Ipratropium Bromide 0.02% Solution (Preservative Free) Vol. 4 No .6 455
Terbutaline 0.1% Inhalant Solution (Preservative Free) Vol. 4 No .6 455
Albuterol-Cromolyn-Betamethasone for Inhalation (Preservative Free) Vol. 4 No .6 455
Albuterol-Ipratropium for Inhalation (Preservative Free) Vol. 4 No .6 455
Beclomethasone Dipropionate 0.042% Nasal Solution (Preservative Free) Vol. 4 No .6 455
Estriol and Estradiol 2.5-mg, Progesterone 50-mg, and Testosterone 1-mg Capsules Vol. 4 No .6 458
Estriol and Estradiol 1.25, 2.5, and 5-mg (BiEst) Capsules Vol. 4 No .6 459
Estrogen 0.625-mg/5-g Vaginal Gel Vol. 4 No .6 460
Progesterone Cycle Pack 35/50/75/100-mg Capsules Vol. 4 No .6 461
Testosterone 1-mg/0.1-mL Nasal Spray Vol. 4 No .6 462
Testosterone 1-mg/0.1-mL in a PLO Gel Vol. 4 No .6 463
Testosterone 1-mg/0.1-mL Topical Vaginal/Scrotal Spray Vol. 4 No .6 464
Triple Estrogen 2.5-mg/0.1-mL PLO Vol. 4 No .6 465
Triple Estrogen 2.5-mg/0.1-mL Sublingual Drops Vol. 4 No .6 466
Triple Estrogen 2.5-mg Tablet Triturates Vol. 4 No .6 467
Estrogen Use in Dogs: Indications and Complications Vol. 4 No .6 468
Oleaginous Vehicles, Featured Excipient: Vol. 4 No .6 470
Calculations Vol. 4 No .6 473
Assignment of a Beyond-Use Date for Compounded Preparations Vol. 4 No .6 474
Compatibility and Stability of Linezolid Injection Admixed with Gentamicin Sulfate and Tobramycin Sulfate Vol. 4 No .6 476
Stability of Nafcillin Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 4 No .6 480
Stability of Levothyroxine Sodium Injection in Polypropylene Syringes Vol. 4 No .6 482